Anthrogenesis Corporation

Celularity Inc.

Other

Antrhogenesis Corporation

Clarity Acquisition Ii LLC

Qian Ye

Jia-lun Wang

James W. Edinger

Robert J. Hariri

James W Edinger

Robert J Hariri

Jia-Lun Wang

Kristen S Labazzo

Mohit Bhatia

Jai-Lun Wang

Chris Lugo

Ryhor Harbacheuski

RoseAnn Murray

Casper Paludan

Herbert Faleck

Sascha Dawn Abramson

Aleksandar Francki

Vladimir Jankovic

Marian Pereira

Mohammad A Heidaran

Stewart Abbot

Eric Law

Wolfgang Hofgartner

Aleksandr Kaplunovsky

Xiaokui Zhang

Steven Alan Fischkoff

Lin Kang

Neerav Dilip Padliya

Jennifer Paredes

Bitao Liang

Bhavani Stout

Cynthia Ray

Aleksander Francki

Philippe Martin

Ivana Djuretic

Vanessa Voskinarian-berse

Roseann Murray

Jia-Iun Wang

Marian Periera

Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.

Treatment of inflammatory diseases using placental stem cells

The present invention provides improved compositions and methods for the collection of stem cells from an organ, e.g., placenta. The invention provides a stem cell collection composition comprising an apoptosis inhibitor and, optionally, an enzyme such as a protease or mucolytic enzyme, vasodilator, necrosis inhibitor, oxygen-carrying perfluorocarbon, or an organ preserving compound. The invention provides methods of using the stem cell collection composition to collect stem cells and to preserve populations of stem cells.

Composition for collecting and preserving placental stem cells and methods of using the composition

Provided herein are methods and compositions for the production of hepatocytes from placenta stem cells. Further provided herein is the use of such hepatocytes in the treatment of, and intervention in, for example, trauma, inflammation, and degenerative disorders of the liver. Also provided herein are compositions and methods relating to combinations of nanofibrous scaffolds and adherent placental stem cells and methods of using the same in cartilage repair. Finally, provided herein are compositions and methods relating to nonadherent, CD34CD45stem cells from placenta.

CD34,CD45placental stem cell-enriched cell populations

The present invention provides placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. The invention also provides methods of differentiating the placental stem cells. The invention further provides methods of using the placental stem cells in assays and for transplanting.

Placental stem cell populations

Provided herein are methods of using adherent placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. Also provided herein are methods of differentiating the placental stem cells. Further provided herein are methods of using the placental stem cells to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with stem cells and compositions comprising stem cells.

Methods and compositions for treatment of bone defects with placental cell populations

The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.

Human placental collagen compositions, and methods of making and using the same

Composition for collecting placental stem cells and methods of using the composition

The present invention provides methods of immunomodulation using placental stem cells and placental stem cell populations. The invention also provides methods of producing and selecting placental cells and cell populations on the basis of immunomodulation, and compositions comprising such cells and cell populations.

Immunomodulation using placental stem cells

Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.

Angiogenesis using placental stem cells

Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.

Amnion derived adherent cells

Growing community of inventors

Belford, NJ, United States of America

James W Edinger